Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinaseMasami Kondo, Naoto Oku, Hideo Tsukada et al.|International Journal of Cancer|2003Cited by 78
Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416Yasufumi Katanasaka, Naoto Oku, Tomoko Ida et al.|Cancer Letters|2008Cited by 40